medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2023-19-16-22medalphabet-3296Research ArticleСтатьи«Алгологические узы эндометриоза». Особенности клинического менеджмента пациенток с типичными и нетипичными симптомами эндометриоза‘Algological bonds of endometriosis’. Features of clinical management of patients with typical and atypical symptoms of endometriosishttps://orcid.org/0000-0002-5342-8129ОразовМ. Р.OrazovM. R.

Оразов Мекан Рахимбердыевич, д. м. н., проф. кафедры акушерства и гинекологии с курсом перинатологии

Москва

Orazov Mekan R., DM Sci (habil.), professor of the Dept of Obstetrics and Gynecology with a Course in Perinatology

Moscow

omekan@mail.ruhttps://orcid.org/0000-0002-7428-0469РадзинскийВ. Е.RadzinskyV. E.

Радзинский Виктор Евсеевич, заслуженный деятель науки РФ, член-корреспондент РАН, д. м. н., проф., зав. кафедрой акушерства и гинекологии с курсом перинатологии

Москва

Radzinsky Victor E., Honored Scientist of the Russian Federation, Corresponding Member of the Russian Academy of Sciences, DM Sci (habil.), professor, head of the Dept of Obstetrics and Gynecology with a Course in Perinatology

Moscow

radzinsky@mail.ruhttps://orcid.org/0000-0001-6709-5209ДолговЕ. Д.DolgovE. D.

Долгов Евгений Денисович, клинический ординатор кафедры акушерства и гинекологии с курсом перинатологии

Москва

Dolgov Evgeny D., clinical resident of the Dept of Obstetrics and Gynecology with a Course in Perinatology

Moscow

1586dolgde@gmail.comФГАОУ ВО «Российский университет дружбы народов»РоссияPeoples’ Friendship University of RussiaRussian Federation202305112023019Современная гинекология (2)1622Copyright © Оразов М.Р., Радзинский В.Е., Долгов Е.Д., 20232023Оразов М.Р., Радзинский В.Е., Долгов Е.Д.Orazov M.R., Radzinsky V.E., Dolgov E.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/3296

Эндометриоз по-прежнему остается одним из самых загадочных и контраверсионных заболеваний современной гинекологии. Современные статистические данные демонстрируют чрезвычайную актуальность активного внедрения эффективных терапевтических подходов в повседневную практику клинициста. Однако проблемой является ассоциированный с эндометриозом болевой синдром. Все чаще поднимается вопрос о т. н. атипичных алгологических проявлениях эндометриоза, которые, как казалось ранее, никак не соотносились с патогенезом основного заболевания. В этой связи целью данной статьи являлось предложение трехуровневой патогенетической концепции, способной связать основное проявление эндометриоза (тазовая боль) с другими нередко отдаленными алгологическими паттернами, а также составление алгоритма ведения данных пациенток, исходя из их патогенетического стадирования.

Endometriosis remains one of the most mysterious and controversial diseases in modern gynecology. Contemporary statistical data demonstrate the extreme relevance of actively implementing effective therapeutic approaches into the clinician’s everyday practice. However, a significant challenge associated with endometriosis is the pain syndrome. The question of so-called atypical algological manifestations of endometriosis, which previously seemed unrelated to the pathogenesis of the primary disease, is increasingly raised. In this regard, the aim of this article was to propose a three-level pathogenetic concept capable of linking the primary manifestation of endometriosis (pelvic pain) with other often distant algological patterns, as well as to create an algorithm for managing these patients based on their pathogenetic staging.

эндометриозтазовая больэндометриоз-ассоциированная больдиеногестendometriosispelvic painendometriosis-associated paindienogestReferencesYilmaz B. D., Bulun S. E. Endometriosis and nuclear receptors // Human reproduction update. 2019; 25 (4): 473–485.Yilmaz B. D., Bulun S. E. Endometriosis and nuclear receptors // Human reproduction update. 2019; 25 (4): 473–485.Arnold MJ, Osgood AT, Aust A. Chronic Pelvic Pain in Women: ACOG Updates Recommendations. Am Fam Physician. 2021 Feb 1; 103 (3): 186–188. PMID: 33507045.Arnold MJ, Osgood AT, Aust A. Chronic Pelvic Pain in Women: ACOG Updates Recommendations. Am Fam Physician. 2021 Feb 1; 103 (3): 186–188. PMID: 33507045.Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M, Wei J. Endometriosis. Endocr Rev. 2019 Aug 1; 40 (4): 1048–1079. DOI: 10.1210/er.2018–00242. PMID: 30994890; PMCID: PMC 6693056.Bulun SE, Yilmaz BD, Sison C, Miyazaki K, Bernardi L, Liu S, Kohlmeier A, Yin P, Milad M, Wei J. Endometriosis. Endocr Rev. 2019 Aug 1; 40 (4): 1048–1079. DOI: 10.1210/er.2018–00242. PMID: 30994890; PMCID: PMC 6693056.Simopoulou M., Rapani A., Grigoriadis S., Pantou A., Tsioulou P., Maziotis E., Tzanakaki D., Triantafyllidou O., Kalampokas T., Siristatidis C., Bakas P., Vlahos N. Getting to Know Endometriosis-Related Infertility Better: A Review on How Endometriosis Affects Oocyte Quality and Embryo Development. Biomedicines. 2021; 9: 273. https://doi.org/10.3390/biomedicines9030273Simopoulou M., Rapani A., Grigoriadis S., Pantou A., Tsioulou P., Maziotis E., Tzanakaki D., Triantafyllidou O., Kalampokas T., Siristatidis C., Bakas P., Vlahos N. Getting to Know Endometriosis-Related Infertility Better: A Review on How Endometriosis Affects Oocyte Quality and Embryo Development. Biomedicines. 2021; 9: 273. https://doi.org/10.3390/biomedicines9030273Arnold MJ, Osgood AT, Aust A. Chronic Pelvic Pain in Women: ACOG Updates Recommendations. Am Fam Physician. 2021 Feb 1; 103 (3): 186–188. PMID: 33507045.Arnold MJ, Osgood AT, Aust A. Chronic Pelvic Pain in Women: ACOG Updates Recommendations. Am Fam Physician. 2021 Feb 1; 103 (3): 186–188. PMID: 33507045.Chronic pelvic pain: ACOG Practice Bulletin, Number 218. Obstet Gynecol. 2020; 135: e98–e109. DOI: 10.1097/AOG.0000000000003716Chronic pelvic pain: ACOG Practice Bulletin, Number 218. Obstet Gynecol. 2020; 135: e98–e109. DOI: 10.1097/AOG.0000000000003716Радзинский В. Е., Оразов М. Р., Костин И. Н. Хроническая тазовая боль в гинекологической практике. Доктор.Ру. 2019; 7 (162): 30–35.Radzinsky V. E., Orazov M. R., Kostin I. N. Chronic Pelvic Pain in Gynecological Practice. Doctor.Ru. 2019; 7 (162): 30–35.Bourdel N., Matsusakï S., Roman H., Lenglet Y., Botchorischvili R., Mage G., Canis M. Endometriosis in teenagers. Gynecol. Obstet. Fertil. 2006; 34: 727–734.Bourdel N., Matsusakï S., Roman H., Lenglet Y., Botchorischvili R., Mage G., Canis M. Endometriosis in teenagers. Gynecol. Obstet. Fertil. 2006; 34: 727–734.Briceag I, Costache A, Purcarea VL, Cergan R, Dumitru M, Briceag I, Sajin M, Ispas AT. Fallopian tubes – literature review of anatomy and etiology in female infertility. J. Med Life. 2015; 8 (2): 129–31.Briceag I, Costache A, Purcarea VL, Cergan R, Dumitru M, Briceag I, Sajin M, Ispas AT. Fallopian tubes – literature review of anatomy and etiology in female infertility. J. Med Life. 2015; 8 (2): 129–31.Ballweg M. L. Impact of endometriosis on women’s health: Comparative historical data show that the earlier the onset, the more severe the disease. Best Pract. Res. Clin. Obstet. Gynaecol. 2004; 18: 201–218.Ballweg M. L. Impact of endometriosis on women’s health: Comparative historical data show that the earlier the onset, the more severe the disease. Best Pract. Res. Clin. Obstet. Gynaecol. 2004; 18: 201–218.Greene R., Stratton P., Cleary S. D., Ballweg M. L., Sinaii N. Diagnostic experience among 4334 women reporting surgically diagnosed endometriosis. Fertil. Steril. 2009; 91: 32–39.Greene R., Stratton P., Cleary S. D., Ballweg M. L., Sinaii N. Diagnostic experience among 4334 women reporting surgically diagnosed endometriosis. Fertil. Steril. 2009; 91: 32–39.Оразов М. Р., Радзинский В. Е., Долгов Е. Д. Современные возможности терапевтического менеджмента пациенток с эндометриозом в различные возрастные периоды. Women’s Clinic. 2023; 2: 10–18.Orazov M. R., Radzinsky V. E., Dolgov E. D. Modern Therapeutic Management Options for Patients with Endometriosis in Different Age Groups. Women’s Clinic. 2023; 2: 10–18.Zeitoun K., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., Johns A., Meng L., Putman M., Carr B. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: Failure to metabolize 17β-estradiol. J. Clin. Endocrinol. Metab. 1998; 83: 4474–4480.Zeitoun K., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., Johns A., Meng L., Putman M., Carr B. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: Failure to metabolize 17β-estradiol. J. Clin. Endocrinol. Metab. 1998; 83: 4474–4480.Noble L. S., Takayama K., Zeitoun K. M., Putman J. M., Johns D. A., Hinshelwood M. M., Agarwal V. R., Zhao Y., Carr B. R., Bulun S. E. Prostaglandin E 2 stimulates aromatase expression in endometriosis-derived stromal cells. J. Clin. Endocrinol. Metab. 1997; 82: 600–606.Noble L. S., Takayama K., Zeitoun K. M., Putman J. M., Johns D. A., Hinshelwood M. M., Agarwal V. R., Zhao Y., Carr B. R., Bulun S. E. Prostaglandin E 2 stimulates aromatase expression in endometriosis-derived stromal cells. J. Clin. Endocrinol. Metab. 1997; 82: 600–606.Bulun S. E., Yang S., Fang Z., Gurates B., Tamura M., Zhou J., Sebastian S. Role of aromatase in endometrial disease. J. Steroid Biochem. Mol. Biol. 2001; 79: 19–25.Bulun S. E., Yang S., Fang Z., Gurates B., Tamura M., Zhou J., Sebastian S. Role of aromatase in endometrial disease. J. Steroid Biochem. Mol. Biol. 2001; 79: 19–25.Laganà A. S. et al. The pathogenesis of endometriosis: molecular and cell biology insights // International journal of molecular sciences. 2019; 20 (22): 5615.Laganà A. S. et al. The pathogenesis of endometriosis: molecular and cell biology insights // International journal of molecular sciences. 2019; 20 (22): 5615.Оразов М. Р., Токтар Л. Р. Боль по кругу. StatusPraesens. Гинекология, акушерство, бесплодный брак. 2020; 4: 42–47.Orazov M. R., Toktar L. R. Pain in a Circle. Status Praesens. Gynecology, Obstetrics, Infertility. 2020; 4: 42–47.Smolarz B., Szyłło K., Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature) //International journal of molecular sciences. 2021; 22 (19): 10554.Smolarz B., Szyłło K., Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics (review of literature) //International journal of molecular sciences. 2021; 22 (19): 10554.Яковлева Э. Б., Бабенко О. М., Бугаев А. Б. Современный взгляд на проблему лечения хронической тазовой боли. Медицина неотложных состояний. 2014; 2 (57): 134–139.Yakovleva E. B., Babenko O. M., Bugaev A. B. Modern Perspective on the Treatment of Chronic Pelvic Pain. Emergency Medicine. 2014; 2 (57): 134–139.Русина Е. И., Ярмолинская М. И., Пьянкова В. О. Глубокий инфильтративный эндометриоз. Спорные вопросы: за и против. Гинекология. 2020; 5.Rusina E. I., Yarmolinskaya M. I., Pyankova V. O. Deep Infiltrating Endometriosis. Controversial Issues: Pros and Cons. Gynecology. 2020; 5.Quintana R. L. Endometriosis infiltrativa profunda en la vejiga, resección quirúrgica por laparoscopia. Reporte de un caso y revisión de la bibliografía. REVISTA MEXICANA DE MEDICINA DE LA REPRODUCCIÓN. 2022; 13. – № . d.Quintana R. L. Endometriosis infiltrativa profunda en la vejiga, resección quirúrgica por laparoscopia. Reporte de un caso y revisión de la bibliografía. REVISTA MEXICANA DE MEDICINA DE LA REPRODUCCIÓN. 2022; 13. – № . d.Kor E. et al. Relationship between the severity of endometriosis symptoms (dyspareunia, dysmenorrhea and chronic pelvic pain) and the spread of the disease on ultrasound //BMC Research Notes. 2020; 13: 1–8.Kor E. et al. Relationship between the severity of endometriosis symptoms (dyspareunia, dysmenorrhea and chronic pelvic pain) and the spread of the disease on ultrasound //BMC Research Notes. 2020; 13: 1–8.Gutman G., Nunez A. T., Fisher M. Dysmenorrhea in adolescents //Current Problems in Pediatric and Adolescent Health Care. 2022; 101186.Gutman G., Nunez A. T., Fisher M. Dysmenorrhea in adolescents //Current Problems in Pediatric and Adolescent Health Care. 2022; 101186.Gete D. G., Doust J., Mortlock S., Montgomery G., Mishra G. D. 2023. Associations between endometriosis and common symptoms: findings from the Australian Longitudinal Study on Women’s Health. American Journal of Obstetrics and Gynecology.Gete D. G., Doust J., Mortlock S., Montgomery G., Mishra G. D. 2023. Associations between endometriosis and common symptoms: findings from the Australian Longitudinal Study on Women’s Health. American Journal of Obstetrics and Gynecology.Mechsner S. 2022. Endometriosis, an Ongoing Pain–Step-by-Step Treatment. Journal of Clinical Medicine. 2022; 11 (2): 467.Mechsner S. 2022. Endometriosis, an Ongoing Pain–Step-by-Step Treatment. Journal of Clinical Medicine. 2022; 11 (2): 467.Lai ZZ, Yang HL, Ha SY, Chang KK, Mei J, Zhou WJ, Qiu XM, Wang XQ, Zhu R, Li DJ, Li MQ. Cyclooxygenase‑2 in Endometriosis. Int J. Biol. Sci. 2019 Oct 23; 15 (13): 2783–2797. DOI: 10.7150/ijbs.35128. PMID: 31853218; PMCID: PMC 6909960Lai ZZ, Yang HL, Ha SY, Chang KK, Mei J, Zhou WJ, Qiu XM, Wang XQ, Zhu R, Li DJ, Li MQ. Cyclooxygenase‑2 in Endometriosis. Int J. Biol. Sci. 2019 Oct 23; 15 (13): 2783–2797. DOI: 10.7150/ijbs.35128. PMID: 31853218; PMCID: PMC 6909960Kim H. J. et al. Dienogest May Reduce Estradiol-and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture-and Mouse Model-Based Study. Biomedicines. 2022; 10 (11): 2992.Kim H. J. et al. Dienogest May Reduce Estradiol-and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture-and Mouse Model-Based Study. Biomedicines. 2022; 10 (11): 2992.Оразов М. Р., Радзинский В. Е., Долгов Е. Д., Абрамашвили Ю. Г. Патогенез и патогенетические опции в менеджменте эндометриоза. Вопросы гинекологии, акушерства и перинатологии. 2023; 22(1): 92–104. DOI: 10.20953/1726–1678–2023–1–92–104Orazov M. R., Radzinsky V. E., Dolgov E. D., Abramashvili Yu. G. Pathogenesis and Pathogenetic Options in the Management of Endometriosis. Issues in Gynecology, Obstetrics, and Perinatology. 2023; 22 (1): 92–104. DOI: 10.20953/1726–1678–2023–1–92–104Оразов М. Р., Радзинский В. Е., Орехов Р. Е., Таирова М. Б. Эффективность профилактики рецидивов после хирургического лечения эндометриоза яичников. Вопросы гинекологии, акушерства и перинатологии. 2022; 21 (3): 53.Orazov M. R., Radzinsky V. E., Orekhov R. E., Tairova M. B. The Effectiveness of Preventing Recurrences after Surgical Treatment of Ovarian Endometriosis. Issues in Gynecology, Obstetrics, and Perinatology. 2022; 21 (3): 53.Uludag S. Z., Demirtas E., Sahin Y., Aygen E. M. Dienogest reduces endometrioma volume and endometriosis-related pain symptoms. Journal of Obstetrics and Gynaecology. 2021; 41 (8): 1246–1251.Uludag S. Z., Demirtas E., Sahin Y., Aygen E. M. Dienogest reduces endometrioma volume and endometriosis-related pain symptoms. Journal of Obstetrics and Gynaecology. 2021; 41 (8): 1246–1251.Vignali M., Belloni G. M., Pietropaolo G., Barbasetti Di Prun A., Barbera V., Angioni S., Pino I. Effect of Dienogest therapy on the size of the endometrioma. Gynecological Endocrinology. 2020; 36 (8): 723–727.Vignali M., Belloni G. M., Pietropaolo G., Barbasetti Di Prun A., Barbera V., Angioni S., Pino I. Effect of Dienogest therapy on the size of the endometrioma. Gynecological Endocrinology. 2020; 36 (8): 723–727.Bono Y., Kyo S., Kiyono T., Mizumoto Y., Nakamura M., Maida Y., Takakura M., Fujiwara H. Concurrent estrogen action was essential for maximal progestin effect in oral contraceptives. Fertility and Sterility. 2014; 101: 5.Bono Y., Kyo S., Kiyono T., Mizumoto Y., Nakamura M., Maida Y., Takakura M., Fujiwara H. Concurrent estrogen action was essential for maximal progestin effect in oral contraceptives. Fertility and Sterility. 2014; 101: 5.Mueck A. O., Sitruk-Ware R. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids. 2011; 76 (6): 531–539.Mueck A. O., Sitruk-Ware R. Nomegestrol acetate, a novel progestogen for oral contraception. Steroids. 2011; 76 (6): 531–539.

The authors declare that there are no conflicts of interest present.